Videos

Ubrogepant: Treatment for Acute Migraine

Rimegepant: Treatment for Acute Migraine

Patient Selection for Acute Migraine Therapy

Acute Migraine Treatment Goals

Treatment Goals for Acute Migraine

Treating Acute Migraine in the Community Setting

Acute Migraine Treatment: What’s Next?

Real-World Experience With Gepants for Acute Migraine

Gepants for Acute Migraine: Patient Management

Gepants for Acute Migraine: Safety & Efficacy Data

Advances in the Treatment of Acute Migraine

Burden of Migraine

Jennifer Frontera, MD: Neurologic Implications of COVID-19 Infection

Jennifer Frontera, MD

Joe Verghese, MBBS, MS: Characteristics of Motoric Cognitive Risk Syndrome

The professor of neurology at the NYU Langone Grossman School of Medicine gave her reaction to the data she and colleagues published on neurologic disorders in patients with COVID-19.

Joe Verghese, MBBS, MS

October 29th 2020

Behavioral and Lifestyle Strategies for Migraine Management

The director of the Montefiore Einstein Center for the Aging Brain detailed the symptoms of motoric cognitive risk syndrome and how they compare to more typical mild cognitive impairment.

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Patient Selection for Neuromodulation Devices

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Role of Neuromodulation for Acute Treatment of Migraine

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Patient Selection of Novel Therapies for Migraine Treatment

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Intranasal DHE in Acute Treatment of Migraine

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Use of 5-HT1F Agonists in Acute Treatment of Migraine

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Acute Treatment of Migraine: Progress With Novel Medications

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Evolution of Acute Treatment of Migraine

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Acute Treatment of Migraine: Traditional Therapies

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Unmet Needs in the Management of Migraine

Peter J. Goadsby, MD, PhD, DSc;Dawn C. Buse, PhD;Jelena Pavlovic, MD, PhD;Wade M. Cooper, DO;Paul G. Mathew, MD, DNPAS, FAAN, FAHS

David Vossler, MD: Treating Generalized Tonic-Clonic Seizures

David Vossler, MD

Raman Malhotra, MD: Lasting Challenges in Sleep Medicine

The Medical Director of The Neuroscience Institute at UW Medicine Valley Medical Center discussed the landscape of therapy for tonic-clonic seizures and how lacosamide might fit into the paradigm.

Raman Malhotra, MD

October 27th 2020

Anup Patel, MD: Challenges Associated With Lennox-Gastaut Syndrome

The associate professor of neurology at Washington University in St. Louis discussed the challenges that sleep specialists continue to face despite a number of recent advances in the space.

Anup Patel, MD

October 27th 2020